Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

This article was originally published here

BNT162, which is being developed for giving protection against SARS-CoV-2, the virus that causes Covid-19, was recently given the fast track designation by the US Food and Drug

The post Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply